Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Multiple Myeloma
Multiple Myeloma
FDA declines to approve Regeneron's blood cancer therapy
Reuters
Tue, 08/20/24 - 09:59 pm
Regeneron
FDA
linvoseltamab
Multiple Myeloma
GSK plots Blenrep's plot back to market with EU filing
BioSpace
Mon, 07/22/24 - 11:33 am
GSK
Blenrep
relaunch
Multiple Myeloma
Europe
J&J, Legend's Carvykti shows CAR-T can extend lives in multiple myeloma
Fierce Pharma
Tue, 07/2/24 - 11:22 am
JNJ
Legend Biotech
CAR-T
Carvykti
Multiple Myeloma
clinical trials
From market withdrawal back to £3B peak sales: GSK dreams big for myeloma ADC Blenrep
Fierce Pharma
Mon, 06/17/24 - 10:32 pm
GSK
Blenrep
Multiple Myeloma
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena
Thu, 06/6/24 - 11:31 am
AbbVie
clinical trials
ABBV-383
Multiple Myeloma
Kite and Arcellx prepare to launch Phase III multiple myeloma trial
Clinical Trials Arena
Mon, 05/13/24 - 11:22 am
Kite Pharma
Gilead Sciences
Arcellx
clinical trials
anito-cel
Multiple Myeloma
As FDA weighs another myeloma endpoint for accelerated approvals, experts say timely access is at stake
Fierce Pharma
Tue, 04/9/24 - 11:36 am
FDA
Multiple Myeloma
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
BioSpace
Mon, 03/11/24 - 11:53 am
CAR-T
Multiple Myeloma
FDA
Bristol Myers Squibb
2seventy bio
Abecma
JNJ
Legend Biotech
Carvykti
FDA Rescinds Approval of Oncopeptides' Blood Cancer Treatment: Implications and What's Next
Medriva
Mon, 02/26/24 - 10:44 am
Oncopeptides
Pepaxto
FDA
Multiple Myeloma
Bi-weekly dose of Johnson & Johnson's blood cancer therapy gets US FDA approval
Reuters
Tue, 02/20/24 - 05:54 pm
JNJ
Tecvayli
FDA
Multiple Myeloma
GSK’s Blenrep Combo Scores Phase III Win in Multiple Myeloma
BioSpace
Tue, 02/6/24 - 09:25 am
GSK
Blenrep
Multiple Myeloma
clinical trials
J&J, Legend to Face Adcomm for Carvykti’s Push as Earlier Line MM Treatment
BioSpace
Wed, 01/24/24 - 10:40 am
JNJ
Legend Biotech
FDA
Carvykti
Multiple Myeloma
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Fierce Pharma
Wed, 12/13/23 - 09:45 am
ASH 2023
JNJ
Sanofi
Darzalex
Sarclisa
Multiple Myeloma
Sanofi’s Phase III multiple myeloma trial meets primary goal
Clinical Trials Arena
Fri, 12/8/23 - 11:02 am
Sanofi
cliincal trials
Sarclisa
Multiple Myeloma
monoclonal antibodies
Regeneron touts possible 'best-in-class' myeloma bispecific, but adverse events climb to 100%
Fierce Biotech
Thu, 12/7/23 - 11:52 am
Regeneron
clinical trials
bispecific
Multiple Myeloma
patient deaths
linvoseltamab
GSK cancer drug Blenrep gets surprise trial win
BioPharma Dive
Tue, 11/28/23 - 10:19 am
GSK
Blenrep
clinical trials
Multiple Myeloma
Legend Biotech to Showcase Leadership in Multiple Myeloma Treatment at the ASH 2023 Annual Meeting
BioSpace
Thu, 11/2/23 - 11:36 am
Legend Biotech
Multiple Myeloma
cilta-cel
ASH 2023
After launch limitations, Johnson & Johnson exec touts manufacturing progress on CAR-T drug Carvykti
Fierce Pharma
Wed, 10/18/23 - 07:44 pm
JNJ
Legend Biotech
Multiple Myeloma
CAR-T
Carvykti
cell therapy
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
FDA
Alnylam
Onpattro
ATTR amyloidosis
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
Bluebird Bio
Zynteglo
sickle cell disease
Bristol Myers Squibb
2seventy bio
Abecma
Multiple Myeloma
Amgen
Lumakras
non-small cell lung cancer
Pfizer
estrasimod
ulcerative colitis
AbbVie’s venetoclax fails Phase III myeloma trial
Clinical Trials Arena
Mon, 10/2/23 - 10:12 am
AbbVie
venetoclax
Multiple Myeloma
clinical trials
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »